References
- SorrellMFBelongiaEACostaJNational Institutes of Health Consensus Development Conference Statement: management of hepatitis BAnn Intern Med2009150210411019124811
- TakeharaTTatsumiTSuzukiTHepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responsesGastroenterology200412741189119715480996
- VickBWeberAUrbanikTKnockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytesHepatology200949262763619127517
- FriedmanSLMechanisms of hepatic fibrogenesisGastroenterology200813461655166918471545
- MalhiHGuicciardiMEGoresGJHepatocyte death: a clear and present dangerPhysiol Rev20109031165119420664081
- HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
- HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
- CanbayAFriedmanSGoresGJApoptosis: the nexus of liver injury and fibrosisHepatology200439227327814767974
- FerlayJShinHRBrayFEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer20101272893291721351269
- GishRGMarreroJABensonABA multidisciplinary approach to the management of hepatocellular carcinomaGastroenterol Hepatol (N Y)201063 Suppl 7S1S16
- BoschFXRibesJDíazMClériesRPrimary liver cancer: worldwide incidence and trendsGastroenterology20041275 Suppl 1S5S1615508102
- SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
- RahibLSmithBDAizenbergRRosenzweigABFleshmanJMMatrisianLMProjecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United StatesCancer Res201474112913292124840647
- El-SeragHBHepatocellular carcinoma: recent trends in the United StatesGastroenterology20041275 Suppl 1S27S3415508094
- FeitelsonMASunBSatiroglu TufanNLLiuJPanJLianZGenetic mechanisms of hepatocarcinogenesisOncogene200221162593260411971194
- MishraLBankerTMurrayJLiver stem cells and hepatocellular carcinomaHepatology200949131832919111019
- BraicuCBurzCBerindan-NeagoeIHepatocellular carcinoma: tumorigenesis and prediction markersGastroenterology Res200924191199
- TangYKitisinKJogunooriWProgenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signalingProc Natl Acad Sci U S A200810572445245018263735
- MajumdarACurleySAWuXHepatic stem cells and transforming growth factor β in hepatocellular carcinomaNat Rev Gastroenterol Hepatol20129953053822710573
- LiuMLeeDFChenCTIKKα activation of NOTCH links tumorigenesis via FOXA2 suppressionMol Cell201245217118422196886
- EndoKUedaTUeyamaJOhtaTTeradaTImmunoreactive E- cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients’ survivalHum Pathol200031555856510836294
- LimSOGuJMKimMSEpigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoterGastroenterology200813562128214018801366
- D’AnzeoMFaloppiLScartozziMThe role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatmentMolecules20141956393640624853455
- BruixJShermanMAmerican Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
- International Consensus Group for Hepatocellular NeoplasiaPathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular NeoplasiaHepatology200949265866419177576
- HuBTianXSunJMengXEvaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysisInt J Mol Sci20131412235592358024317431
- RichNSingalAGHepatocellular carcinoma tumour markers: current role and expectationsBest Pract Res Clin Gastroenterol201428584385325260312
- KamiyamaTYokooHFurukawaJIdentification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysisHepatology20135762314232523322672
- GonzalezSANovel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?Hepatobiliary Surg Nutr20143641041425568864
- SchoenbachKHBeebeSJBuescherESIntracellular effect of ultrashort electrical pulsesBioelectromagnetics200122644044811536285
- BeebeSJApplications for pulse power using nanosecond pulsed electric fields (nsPEFs) in cell biology and cancer treatmentJ Nanomed Biotherapeut Discov20133e123
- BeebeSJMechanisms of nanosecond pulsed electric field (NsPEF)-induced cell death in cells and tumorsJ Nanomed Res20152100016
- BeebeSJBioelectrics in basic science and medicine: impact of electric fields on cellular structures and functionsJ Nanomed Nanotechnol2013421000163
- BeebeSJCell responses without receptors and ligands, using nanosecond pulsed electric fields (nsPEFs)Int J Nanomedicine201383401340424039422
- VernierPTSunYGundersenMANanoelectropulse-driven membrane perturbation and small molecule permeabilizationBMC Cell Biol200673717052354
- PakhomovAGBowmanAMIbeyBLAndreFMPakhomovaONSchoenbachKHLipid nanopores can form a stable, ion channel-like conduction pathway in cell membraneBiochem Biophys Res Commun2009385218118619450553
- StewartDAGowrishankarTRWeaverJCTransport lattice approach to describing electroporation: use of local asymptotic modelIEEE Trans Plasma Sci200432416961708
- GowrishankarTREsserATVasilkoskiZSmithKCWeaverJCMicrodosimetry for conventional and supra-electroporation in cells with organellesBiochem Biophys Res Commun200634141266127616469297
- NuccitelliRPliquettUChenXNanosecond pulsed electric fields cause melanomas to self-destructBiochem Biophys Res Commun2006343235136016545779
- NuccitelliRTranKAthosBNanoelectroablation therapy for murine basal cell carcinomaBiochem Biophys Res Commun2012424344645022771794
- NuccitelliRTranKLuiKNon-thermal nanoelectroablation of UV-induced murine melanomas stimulates an immune responsePigment Cell Melanoma Res201225561862922686288
- NuccitelliRHuynhJLuiKNanoelectroablation of human pancreatic carcinoma in a murine xenograft model without recurrenceInt J Cancer201313281933193923001643
- ChenXKolbJFSwansonRJSchoenbachKHBeebeSJApoptosis initiation and angiogenesis inhibition: melanoma targets for nanosecond pulsed electric fieldsPigment Cell Melanoma Res201023455456320370854
- ChenXZhuangJKolbJFSchoenbachKHBeebeSJLong term survival of mice with hepatocellular carcinoma after pulse power ablation with nanosecond pulsed electric fieldsTechnol Cancer Res Treat2012111839322181334
- ChenRSainNMHarlowKTA protective effect after clearance of orthotopic rat hepatocellular carcinoma by nanosecond pulsed electric fieldsEur J Cancer201450152705271325081978
- NuccitelliRWoodRKreisMFirst-in-human trial of nanoelectroablation therapy for basal cell carcinoma: proof of methodExp Dermatol201423213513724330263
- BruixJLlovetJMPrognostic prediction and treatment strategy in hepatocellular carcinomaHepatology200235351952411870363
- ComptonCCByrdDRGarcia-AguilarJAJCC Cancer Staging AtlasNew YorkSpringer-Verlag2012
- ChildCTurcotteJThe liver and portal hypertensionChildCGSurgery and Portal HypertensionPhiladelphia, PAWB Saunders Co Ltd19645058
- PughRNMurray-lyonIMDawsonJLPietroniMCWilliamsRTransection of the oesophagus for bleeding oesophageal varicesBr J Surg19736086466494541913
- LlovetJMBrúCBruixJPrognosis of hepatocellular carcinoma: the BCLC staging classificationSemin Liver Dis199919332933810518312
- LlovetJMFusterJBruixJBarcelona-Clínic Liver Cancer GroupThe Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinomaLiver Transpl2004102 Suppl 1S115S12014762851
- Abou-AlfaGKSchwartzLRicciSPhase II study of sorafenib in patients with advanced hepatocellular carcinomaJ Clin Oncol200624264293430016908937
- VillanuevaAMinguezBFornerAReigMLlovetJMHepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapyAnnu Rev Med20106131732820059340
- LongGShiresPKPlesciaDBeebeSJKolbJFSchoenbachKHTargeted tissue ablation with nanosecond pulsesIEEE Trans Biomed Eng201158821612167
- RenWSainNMBeebeSJNanosecond pulsed electric fields (nsPEFs) activate intrinsic caspase-dependent and caspase- independent cell death in Jurkat cellsBiochem Biophys Res Commun2012421480881222554515
- BeebeSJSainNMRenWInduction of cell death mechanisms and apoptosis by nanosecond pulsed electric fields (nsPEFs)Cells20132113616224709649
- PakhomovaONGregoryBWSemenovIPakhomovAGTwo modes of cell death caused by exposure to nanosecond pulsed electric fieldPLoS One201387e7027823894630
- Morotomi-YanoKAkiyamaHYanoKDifferent involvement of extracellular calcium in two modes of cell death induced by nanosecond pulsed electric fieldsArch Biochem Biophys2014555–5564754
- IbeyBLPakhomovAGGregoryBWSelective cytotoxicity of intense nanosecond-duration electric pulses in mammalian cellsBiochim Biophys Acta20101800111210121920691249
- GreenDRFergusonTZitvogelLKroemerGImmunogenic and tolerogenic cell deathNat Rev Immunol20099535336319365408
- KroemerG1GalluzziLKeppOZitvogelLImmunogenic cell death in cancer therapyAnnu Rev Immunol201331517223157435
- CasaresNPequignotMOTesniereACaspase-dependent immunogenicity of doxorubicin-induced tumor cell deathJ Exp Med2005202121691170116365148
- BlachèreNEDarnellRBAlbertMLApoptotic cells deliver processed antigen to dendritic cells for cross-presentationPLoS Biol200536e18515839733
- AlbertMLPearceSFFranciscoLMImmature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytesJ Exp Med19981887135913689763615
- SauterBAlbertMLFranciscoLLarssonMSomersanSBhardwajNConsequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cellsJ Exp Med2000191342343410662788
- BasuSBinderRJSutoRAndersonKMSrivastavaPKNecrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathwayInt Immunol200012111539154611058573
- UhlMKeppOJusforgues-SaklaniHVicencioJMKroemerGAlbertMLAutophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cellsCell Death Differ2009167991100519229247
- MichaudMMartinsISukkurwalaAQAutophagy-dependent anticancer immune responses induced by chemotherapeutic agents in miceScience201133460621573157722174255
- ObeidMTesniereAGhiringhelliFCalreticulin exposure dictates the immunogenicity of cancer cell deathNat Med2007131546117187072
- PanaretakisTKeppOBrockmeierUMechanisms of pre-apoptotic calreticulin exposure in immunogenic cell deathEMBO J200928557859019165151
- KeppOTesniereAZitvogelLKroemerGThe immunogenicity of tumor cell deathCurr Opin Oncol2009211717619125021
- GuoZSLiuZBartlettDLOncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunityFront Oncol201447424782985
- SounniNENoelATargeting the tumor microenvironment for cancer therapyClin Chem2013591859323193058
- DalerbaPChoRWClarkeMFCancer stem cells: models and conceptsAnnu Rev Med20075826728417002552
- MageeJAPiskounovaEMorrisonSJCancer stem cells: impact, heterogeneity, and uncertaintyCancer Cell201221328329622439924